Acalabrutinib and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Acalabrutinib (acalabrutinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Allopurinol, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Dizziness when taking Acalabrutinib. It is created by eHealthMe based on reports of 1,237 people who have side effects when taking Acalabrutinib from the FDA, and is updated regularly.

What is Acalabrutinib?

Acalabrutinib has active ingredients of acalabrutinib. eHealthMe is studying from 1,237 Acalabrutinib users. Check the latest studies of Acalabrutinib.

What is Dizziness?

Dizziness is found to be associated with 3,566 drugs and 5,710 conditions by eHealthMe. Check the latest studies of Dizziness.

On Jul, 15, 2026

1,237 people reported to have side effects when taking Acalabrutinib.
Among them, 17 people (1.37%) have Dizziness.

Among these 17 people:

How long have people been on Acalabrutinib when they have Dizziness? *

What is the gender of people who have Dizziness when taking Acalabrutinib? *

female: 43.75 %
male: 56.25 %

What is the age of people who have Dizziness when taking Acalabrutinib? *

What are other drugs people take besides Acalabrutinib? *

What are other side effects people have besides Dizziness? *

Weakness: 3 people, 17.65%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Anaemia (lack of blood): 2 people, 11.76%
Diarrhea: 2 people, 11.76%
Headache (pain in head): 2 people, 11.76%
Head Injury: 2 people, 11.76%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 11.76%
Muscle Spasms (muscle contraction): 2 people, 11.76%
Nausea (feeling of having an urge to vomit): 2 people, 11.76%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 2 people, 11.76%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 35.29%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 17.65%
High Blood Pressure: 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 11.76%
Cardiac Failure: 2 people, 11.76%
Depression: 2 people, 11.76%
Pain: 2 people, 11.76%
Pain In Extremity: 2 people, 11.76%
Pneumonia: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Acalabrutinib and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acalabrutinib:

Acalabrutinib (1,237 reports)

Dizziness treatments and more:

Dizziness (613,960 reports)

Browse all side effects of Acalabrutinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,566 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,710 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acalabrutinib (the active ingredients of Acalabrutinib) and Acalabrutinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.